MATRIX Research Group, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands; Epigenetic Editing Research Group, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
MATRIX Research Group, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
J Biol Chem. 2015 Nov 20;290(47):28465-28476. doi: 10.1074/jbc.M114.634311. Epub 2015 Oct 2.
PLOD2 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2) hydroxylates lysine residues in collagen telopeptides and is essential for collagen pyridinoline cross-link formation. PLOD2 expression and subsequent pyridinoline cross-links are increased in fibrotic pathologies by transforming growth factor β-1 (TGFβ1). In this report we examined the molecular processes underlying TGFβ1-induced PLOD2 expression. We found that binding of the TGFβ1 pathway related transcription factors SMAD3 and SP1-mediated TGFβ1 enhanced PLOD2 expression and could be correlated to an increase of acetylated histone H3 and H4 at the PLOD2 promoter. Interestingly, the classical co-activators of SMAD3 complexes, p300 and CBP, were not responsible for the enhanced H3 and H4 acetylation. Depletion of SMAD3 reduced PLOD2 acetylated H3 and H4, indicating that another as of yet unidentified histone acetyltransferase binds to SMAD3 at PLOD2. Assessing histone methylation marks at the PLOD2 promoter depicted an increase of the active histone mark H3K79me2, a decrease of the repressive H4K20me3 mark, but no role for the generally strong transcription-related modifications: H3K4me3, H3K9me3 and H3K27me3. Collectively, our findings reveal that TGFβ1 induces a SP1- and SMAD3-dependent recruitment of histone modifying enzymes to the PLOD2 promoter other than the currently known TGFβ1 downstream co-activators and epigenetic modifications. This also suggests that additional activation strategies are used downstream of the TGFβ1 pathway, and hence their unraveling could be of great importance to fully understand TGFβ1 activation of genes.
PLD2(脯氨酰-赖氨酸,2-氧戊二酸 5-双加氧酶 2)羟化胶原蛋白末端肽中的赖氨酸残基,对于胶原蛋白吡啶交联的形成至关重要。转化生长因子β-1(TGFβ1)可增加纤维化病变中的 PLD2 表达和随后的吡啶交联。在本报告中,我们研究了 TGFβ1 诱导 PLD2 表达的分子过程。我们发现,TGFβ1 途径相关转录因子 SMAD3 和 SP1 的结合增强了 PLD2 的表达,并且可以与 PLD2 启动子上乙酰化组蛋白 H3 和 H4 的增加相关。有趣的是,SMAD3 复合物的经典共激活因子 p300 和 CBP 并非增强 H3 和 H4 乙酰化的原因。SMAD3 的耗竭降低了 PLD2 乙酰化的 H3 和 H4,表明另一种尚未确定的组蛋白乙酰转移酶在 PLD2 处与 SMAD3 结合。评估 PLD2 启动子上的组蛋白甲基化标记显示,活性组蛋白标记 H3K79me2 增加,抑制性 H4K20me3 标记减少,但通常与转录相关的修饰:H3K4me3、H3K9me3 和 H3K27me3 没有作用。总之,我们的研究结果表明,TGFβ1 诱导 SP1 和 SMAD3 依赖性募集组蛋白修饰酶到 PLD2 启动子,而不是目前已知的 TGFβ1 下游共激活因子和表观遗传修饰。这也表明 TGFβ1 途径下游还使用了其他激活策略,因此深入了解这些策略对于充分理解 TGFβ1 对基因的激活至关重要。